| http://www.w3.org/ns/prov#value | - Agent: 20120190695 - Phenyloxadiazole derivatives as pgds inhibitors: wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (CO
|
